Cargando…
Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2
Laboratories faced many challenges throughout the COVID-19 pandemic. Point-of-care (POC) SARS-CoV-2 nucleic acid amplification tests (NAATs) provided a key solution to the need for rapid turnaround time in select patient populations and were implemented at the POC but also within laboratories to sup...
Autores principales: | Tolan, Nicole V., Horowitz, Gary L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894858/ https://www.ncbi.nlm.nih.gov/pubmed/35636823 http://dx.doi.org/10.1016/j.cll.2022.03.002 |
Ejemplares similares
-
Innovations in infectious disease diagnostics
por: Tolan, Nicole V., et al.
Publicado: (2023) -
Comparative Diagnostic Accuracy of the STANDARD M10 Assay for the Molecular Diagnosis of SARS-CoV-2 in the Point-of-Care and Critical Care Settings
por: Domnich, Alexander, et al.
Publicado: (2022) -
A rapid point of care immunoswab assay for SARS-CoV detection
por: Kammila, Sriram, et al.
Publicado: (2008) -
Comparison of the Clinical Performance of the Point-of-care STANDARD M10 SARS-CoV-2 and Xpert Xpress SARS-CoV-2 Assays
por: Hong, Ki Ho, et al.
Publicado: (2023) -
Current molecular diagnostics assays for SARS-CoV-2 and emerging variants
por: Banks, Jonathan M., et al.
Publicado: (2022)